Insider Selling: Intuitive Surgical (NASDAQ:ISRG) EVP Sells 28 Shares ...
📉 EVP Mark Brosius sold 28 shares of ISRG stock for $10,085.88 under a pre-arranged Rule 10b5-1 trading plan on July 29th.
💰 The company reported Q3 EPS of $2.80, beating the consensus estimate of $2.48 by $0.32.
📈 Revenue reached $2.89 billion for the quarter, representing an 18.4% increase year-over-year.
🏦 Institutional ownership remains high at 83.64%, with North Star Investment Management increasing its stake by 8.5% in Q4.
📉 Goldman Sachs lowered its price target to $558, while BTIG Research reduced its target from $512 to $469.
📊 The stock trades at a P/E ratio of 40.45 with an average analyst target price of $517.21.
🔬 Intuitive Surgical is best known for its da Vinci surgical systems used in minimally invasive procedures.
Bullish Signals
- Intuitive Surgical beat earnings expectations significantly, reporting $2.80 EPS versus the consensus of $2.48.
- Revenue growth was robust at 18.4% year-over-year, reaching $2.89 billion for the quarter.
- The company maintains strong profitability with a net margin of 28.45% and a return on equity of 16.91%.
- Several institutional investors increased their holdings in Q4, including North Star Investment Management Corp which added 8.5% to its position.
Risk Factors
- Analyst price targets have been reduced recently by Goldman Sachs and BTIG Research, indicating some caution on valuation levels.
- The stock is trading below its 50-day and 200-day moving averages at $353.10 versus $401.70 and $454.32 respectively.
Full Analysis
Intuitive Surgical (ISRG) EVP Mark Brosius sold 28 shares of the company's stock on July 29th for a total value of $10,085.88 at an average price of $360.21 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan and resulted in a 2.07% decrease in his direct ownership position, leaving him with 1,322 shares valued at approximately $476,198.
The company recently reported strong quarterly financial results announced on July 16th, beating analyst expectations for both earnings per share and revenue. Intuitive Surgical posted EPS of $2.80 compared to a consensus of $2.48 and generated revenue of $2.89 billion against an estimate of $2.83 billion. Revenue grew by 18.4% year-over-year, while the company maintained a net margin of 28.45% and a return on equity of 16.91%.
Institutional investor activity shows mixed signals with several funds increasing their stakes in the fourth quarter, including North Star Investment Management Corp which raised its position by 8.5%. However, analyst sentiment has softened recently, with Goldman Sachs lowering its price target to $558 and BTIG Research reducing its target from $512 to $469 while maintaining a buy rating.
Intuitive Surgical continues to dominate the robotic-assisted surgery market with its da Vinci systems, which are used in minimally invasive procedures at hospitals and surgical centers globally. The company's stock currently trades at a price-to-earnings ratio of 40.45 with an average analyst target price of $517.21 based on ratings from twenty-one analysts.
